Drug safety in children. All that paediatric clinical trials cannot do;Sicurezza dei farmaci nei bambini Quello che i trial clinici pediatrici non possono fare

Quaderni ACP

Volumn 14, Issue 6, 2007, Pages 266-268

  Salvo, Francesco ^a   Caputi, Achile Patrizio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Adverse reactions; Pharmacovigilance; Surveillance network

Indexed keywords

ANTIBIOTIC AGENT; VACCINE;

ARTICLE; CHILD HEALTH CARE; DRUG EFFICACY; DRUG FATALITY; DRUG RESEARCH; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG TOLERABILITY; DRUG USE; E-MAIL; FOOD AND DRUG ADMINISTRATION; HUMAN; ITALY; MEDICAL EDUCATION; OFF LABEL DRUG USE; PEDIATRICIAN; PHARMACEUTICAL CARE; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; RISK BENEFIT ANALYSIS;

EID: 38349133393     PISSN: None     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Menniti-Ippolito F, Traversa G, Da Cas R, et al. Sicurezza dei farmaci in pediatria. Rapporti ISTISAN 06/16,2006.
2. Bonati M, Choonara I, Hoppu K, et al. Closing the gap in drug therapy. Lancet 1999; 353:1625.
3. Cuzzolin L, Atzei A, Fanos V. Off-label and unlicensed prescribing for newborns and children in different settings: a review of the literature and a consideration about drug safety. Exp Opin Drug Saf 2006;5:703-18.
4. http://www.fda.gov/cder/pediatric/labelchange.htm.
5. http://www.euractiv.com/en/health/medicine/schildren/article-132015.
6. Cote CJ, Karl HW, Notterman DA, et al. Adverse sedation events in pediatrics: analysis of medications used for sedation. Pediatrics 2000;106:633-44.
7. Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54:665-70.
8. McIntyre J, Conroy S, Avery A, et al. Unlicensed and off label prescribing of drugs in general practice. Arch Dis Child 2000;83:498-501.
9. Chalumeau M, Treluyer JM, Salanave B, et al. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 2000; 83:502-5.
10. Wilton L, Pearce G, Mann R. The use of newly marketed drugs in children and adolescents prescribed in general practice. Pharmacoepidemiol Drug Saf 1999;8:S37-S45.
11. Choonara I, Cortroy S. Unlicensed and off-label drug use in children: implication for safety. Drug Saf 2002;25:1-5.
12. Impicciatore P, Choonara I, Clarkson A, et al. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and metanalysis of prospective studies. Br J Clin Pharmacol 2001;52:77-83.
13. Menniti-Ippolito F, Raschetti R, Da Cas R, et al., for the Italian Paediatric Pharmacosurveillance Multicenter Group. Active monitoring of adverse reactions in children. Lancet 2000;355:1613-4.
14. Haffner S, von Laue N, Wirth S, Thürmann PA. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Saf 2005; 28:453-64.
15. Buajordet I, Wesenberg F, Brørs O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian University Hospital. Acta Paediatr 2002;91:88-94.
16. Menniti-Ippolito F, Da Cas R, Bolli M, Capuano A. Studio multicentrico sulla sicurezza dai farmaci in pediatria. Quaderni acp 2007; 14:98-102.
17. Moore TJ, Weiss SR, Kaplan S, Blaisdell CJ. Reported adverse drug events in infants and children under 2 years of age. Pediatrics 2002;110: e53.
18. FDA Center for Drug Evaluation and Research Report to the Nation: Improving Public Health Through Human Drugs. Rockville, MD: Food and Drug Administration, 2002.
19. Cosentino M, Leoni O, Banfi F, et al. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacol Res 1997;35:85-8.
20. Leape LL. Reporting of adverse events. N Engl J Med 2002;347:1633-8.
21. Benichou C. ADR, a practical guide to diagnosis and management. Wiley, 1996.